Lilly’s Eczema Drug Shows Durable Long-Term Response in Late-Stage Study
Eli Lilly said its eczema drug lebrikizumab (Ebglyss) showed durable long-term response in a late-stage study, with data highlighting sustained […]
PATIENTS-EXPERIENCED-PERSISTENT-RELIEF-FROM-ITCH-FOR-UP-TO-FOUR-YEARS
